SUN YAT-SEN MEMORIAL HOSPITAL,SUN YAT-SEN UNIVERSITY

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer

Phase 1

Recruiting

Conditions: Metastatic Breast Cancer
Advanced Breast Cancer

Interventions: Drug: Sacituzumab Govitecan
Drug: Trastuzumab Deruxtecan
Drug: Hydroxychloroquine

First Posted Date: 2024-03-25

Last Posted Date: 2024-03-25

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 120

Registration Number: NCT06328387

Locations: 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Clinically Node-negative Head and Neck Squamous Cell Carcinoma

Phase 2

Recruiting

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Tislelizumab（neoadjuvant）
Drug: Cisplatin （neoadjuvant）
Drug: Nab-paclitaxel （neoadjuvant）
Procedure: Surgical resection
Drug: Cisplatin（adjuvant）
Drug: Tislelizumab（adjuvant）
Radiation: Radiation
Drug: Carboplatin（neoadjuvant）
Drug: Carboplatin（adjuvant）

First Posted Date: 2024-03-21

Last Posted Date: 2024-05-17

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 154

Registration Number: NCT06323369

Locations: 🇨🇳
Medical Ethics Committee of Sun Yat-sen Memorial Hospital, Guangzhou, Yuexiu, China

Adebrelimab and a TKI in Combination With GEMOX in First-line Treatment of Advanced Biliary Tract Cancers (BTC)

Phase 2

Recruiting

Conditions: Biliary Tract Cancer
Gemox Chemotherapy

Interventions: Drug: Adebrelimab + GEMOX + TKI

First Posted Date: 2024-03-20

Last Posted Date: 2024-03-20

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 43

Registration Number: NCT06320301

Locations: 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guanzhou, Guangdong, China

Minimal Access Versus Conventional Latissimus Dorsi Flap Harvest for Breast Reconstruction

Not Applicable

Recruiting

Conditions: Breast Neoplasms

Interventions: Device: minimal access breast reconstruction with a latissimus dorsi muscle flap
Device: conventional breast reconstruction with a latissimus dorsi muscle flap

First Posted Date: 2024-03-19

Last Posted Date: 2024-03-19

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 94

Registration Number: NCT06319157

Locations: 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapy

Phase 3

Recruiting

Conditions: Breast Neoplasms

Interventions: Drug: Carrellizumab + Capecitabine
Drug: Placebo + Capecitabine

First Posted Date: 2024-03-15

Last Posted Date: 2024-03-15

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 375

Registration Number: NCT06313463

Locations: 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

AMH Predicts Postchemotherapy Menopause in Premenopausal Breast Cancer Patients

Not yet recruiting

Conditions: Breast Cancer

First Posted Date: 2024-03-15

Last Posted Date: 2024-03-15

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 153

Registration Number: NCT06313476

Ketogenic Diet in Pediatric Intractable Epilepsy

Not Applicable

Recruiting

Conditions: Epilepsy in Children
Epilepsy Intractable

Interventions: Dietary Supplement: Early ketogenic diet combined with conventional pharmacotherapy.
Drug: Common diet combined with conventional pharmacotherapy

First Posted Date: 2024-03-15

Last Posted Date: 2024-03-15

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 59

Registration Number: NCT06310954

Locations: 🇨🇳
Sun Yat Sen Memorial Hospital， Sun Yat Sen University, Guangzhou, Guangdong, China

Methotrexate Combined With Tofacitinib in Rheumatoid Arthritis

Not Applicable

Not yet recruiting

Conditions: Rheumatoid Arthritis

Interventions: Drug: Methotrexate Combined With Tofacitinib
Drug: Methotrexate

First Posted Date: 2024-03-08

Last Posted Date: 2024-03-08

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 130

Registration Number: NCT06301373

The Analysis of Factors Causing Indwelling Urinary Catheter-related Infections in ICU Patients and Their Nursing Strategies

Completed

Conditions: Catheter-associated Urinary Tract Infection

Interventions: Other: There were no interventions in retrospective analysis

First Posted Date: 2024-03-06

Last Posted Date: 2024-03-06

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 291

Registration Number: NCT06295627

Locations: 🇨🇳
Sun Yat-Sen Memorial Hospital, Canton, Guangdong, China

AI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes Tumors

Recruiting

Conditions: Phyllodes Breast Tumor
Multiomics
Prognostic Cancer Model
Diagnosis
Artificial Intelligence

Interventions: Diagnostic Test: imaging

First Posted Date: 2024-02-29

Last Posted Date: 2024-02-29

Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Target Recruit Count: 4000

Registration Number: NCT06286267

Locations: 🇨🇳
Guangdong Maternal and Child Health Hospital, Guangzhou, Guangdong, China
🇨🇳
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
🇨🇳
The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy